Eton Pharmaceuticals Stock

Eton Pharmaceuticals Stocks 2024

Eton Pharmaceuticals Stocks

25.65 M

Ticker

ETON

ISIN

US29772L1089

WKN

A2N38G

In 2024, Eton Pharmaceuticals had 25.65 M outstanding stocks, a 0% change from the 25.65 M stocks in the previous year.

The Eton Pharmaceuticals Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2026e25.65
2025e25.65
2024e25.65
202325.65
202225.15
202125.21
202021.01
201917.76
201817.61
201716.32

Eton Pharmaceuticals shares outstanding

The number of shares was Eton Pharmaceuticals in 2023 — This indicates how many shares 25.645 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Eton Pharmaceuticals earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Eton Pharmaceuticals's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Eton Pharmaceuticals’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eton Pharmaceuticals's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eton Pharmaceuticals Aktienanalyse

What does Eton Pharmaceuticals do?

The company Eton Pharmaceuticals Inc is an innovative company that specializes in the development of high-quality and reliable medications. The company was founded in 2017 in Deer Park, Illinois, and has since become a leading company in the pharmaceutical industry. Eton Pharmaceuticals Inc's business model is closely related to the development of new medications. The company specializes in the development of so-called "gel-coated" medications, which have better efficacy and tolerability than conventional medications. The company uses innovative and patented technologies to overcome the current limitations of medications and provide customers with the best possible treatment. Eton Pharmaceuticals Inc has different divisions for the development of medications. One of the most important divisions is oncology, where medications for tumor treatment are developed. The company relies on innovative approaches to discover new active substances and improve the treatment of cancer patients. In addition, the company has extensive experience in the production of antibiotics. Eton Pharmaceuticals Inc has developed its own products tailored to the needs of patients, promising fast and effective effects. The company has also developed special medications for the treatment of cardiovascular diseases, aiming to provide patients with a better quality of life. One of the products offered by Eton Pharmaceuticals Inc is the medication "BML-190". This medication is an anti-inflammatory drug used for pain and inflammation. Its special feature is its high effectiveness with minimal side effects, which often occur with other medications. Another product of Eton Pharmaceuticals Inc is the medication "DS-300", used for certain eye diseases. The medication contains an active substance that acts on the eyes and allows for quick healing. Thanks to the innovative technology used in its development, this medication is well tolerated and has minimal side effects. Overall, Eton Pharmaceuticals Inc is an innovative company specializing in the development of high-quality medications. With its business model and expertise in various areas of the pharmaceutical industry, the company is well equipped to continue making significant contributions to healthcare. Eton Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Eton Pharmaceuticals's Shares Outstanding

Eton Pharmaceuticals's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Eton Pharmaceuticals’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Eton Pharmaceuticals’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Eton Pharmaceuticals’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Eton Pharmaceuticals stock

How many stocks are there of Eton Pharmaceuticals?

The current number of stocks of Eton Pharmaceuticals is 25.65 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Eton Pharmaceuticals are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Eton Pharmaceuticals evolved in recent years?

The number of shares of Eton Pharmaceuticals has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Eton Pharmaceuticals as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Eton Pharmaceuticals?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Eton Pharmaceuticals pay?

Over the past 12 months, Eton Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Eton Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Eton Pharmaceuticals?

The current dividend yield of Eton Pharmaceuticals is .

When does Eton Pharmaceuticals pay dividends?

Eton Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Eton Pharmaceuticals?

Eton Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Eton Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Eton Pharmaceuticals located?

Eton Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eton Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eton Pharmaceuticals from 8/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/26/2024.

When did Eton Pharmaceuticals pay the last dividend?

The last dividend was paid out on 8/26/2024.

What was the dividend of Eton Pharmaceuticals in the year 2023?

In the year 2023, Eton Pharmaceuticals distributed 0 USD as dividends.

In which currency does Eton Pharmaceuticals pay out the dividend?

The dividends of Eton Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Eton Pharmaceuticals

Our stock analysis for Eton Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eton Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.